vs
费森尤斯医疗（FMS）与特灵科技（TT）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是特灵科技的1.1倍（$5.5B vs $5.1B），特灵科技净利率更高（11.5% vs 7.9%，领先3.6%），特灵科技同比增速更快（5.5% vs -0.3%）
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
特灵科技是一家注册地位于爱尔兰的企业，核心业务覆盖采暖、通风、空调及制冷系统领域。品牌历史可追溯至150多年前，历经多次并购与分拆：2008年暖通空调厂商特灵被美国工业工具制造商英格索兰收购，2020年工具业务分拆独立为英格索兰，剩余业务正式更名特灵科技。
FMS vs TT — 直观对比
营收规模更大
FMS
是对方的1.1倍
$5.1B
营收增速更快
TT
高出5.8%
-0.3%
净利率更高
TT
高出3.6%
7.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.5B | $5.1B |
| 净利润 | $434.2M | $591.3M |
| 毛利率 | 27.4% | — |
| 营业利润率 | 11.7% | 15.9% |
| 净利率 | 7.9% | 11.5% |
| 营收同比 | -0.3% | 5.5% |
| 净利润同比 | 240.4% | -2.2% |
| 每股收益（稀释后） | — | $2.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMSTT
| Q4 25 | $5.5B | $5.1B | ||
| Q3 25 | — | $5.7B | ||
| Q2 25 | — | $5.7B | ||
| Q1 25 | — | $4.7B | ||
| Q4 24 | $5.5B | $4.9B | ||
| Q3 24 | — | $5.4B | ||
| Q2 24 | — | $5.3B | ||
| Q1 24 | — | $4.2B |
净利润FMSTT
| Q4 25 | $434.2M | $591.3M | ||
| Q3 25 | — | $847.6M | ||
| Q2 25 | — | $874.8M | ||
| Q1 25 | — | $604.9M | ||
| Q4 24 | $127.6M | $604.3M | ||
| Q3 24 | — | $772.0M | ||
| Q2 24 | — | $755.3M | ||
| Q1 24 | — | $436.3M |
毛利率FMSTT
| Q4 25 | 27.4% | — | ||
| Q3 25 | — | 36.9% | ||
| Q2 25 | — | 37.6% | ||
| Q1 25 | — | 35.8% | ||
| Q4 24 | 25.0% | — | ||
| Q3 24 | — | 36.3% | ||
| Q2 24 | — | 36.5% | ||
| Q1 24 | — | 34.6% |
营业利润率FMSTT
| Q4 25 | 11.7% | 15.9% | ||
| Q3 25 | — | 20.3% | ||
| Q2 25 | — | 20.3% | ||
| Q1 25 | — | 17.5% | ||
| Q4 24 | 5.1% | 16.6% | ||
| Q3 24 | — | 18.8% | ||
| Q2 24 | — | 19.5% | ||
| Q1 24 | — | 15.0% |
净利率FMSTT
| Q4 25 | 7.9% | 11.5% | ||
| Q3 25 | — | 14.8% | ||
| Q2 25 | — | 15.2% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | 2.3% | 12.4% | ||
| Q3 24 | — | 14.2% | ||
| Q2 24 | — | 14.2% | ||
| Q1 24 | — | 10.3% |
每股收益（稀释后）FMSTT
| Q4 25 | — | $2.64 | ||
| Q3 25 | — | $3.78 | ||
| Q2 25 | — | $3.89 | ||
| Q1 25 | — | $2.67 | ||
| Q4 24 | — | $2.65 | ||
| Q3 24 | — | $3.39 | ||
| Q2 24 | — | $3.30 | ||
| Q1 24 | — | $1.90 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $1.8B |
| 总债务越低越好 | — | $4.6B |
| 股东权益账面价值 | $15.4B | $8.6B |
| 总资产 | $33.5B | $21.4B |
| 负债/权益比越低杠杆越低 | — | 0.54× |
8季度趋势，按日历期对齐
现金及短期投资FMSTT
| Q4 25 | $1.7B | $1.8B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.3B | $1.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务FMSTT
| Q4 25 | — | $4.6B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $4.8B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益FMSTT
| Q4 25 | $15.4B | $8.6B | ||
| Q3 25 | — | $8.3B | ||
| Q2 25 | — | $7.8B | ||
| Q1 25 | — | $7.5B | ||
| Q4 24 | $17.0B | $7.5B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $6.9B | ||
| Q1 24 | — | $6.9B |
总资产FMSTT
| Q4 25 | $33.5B | $21.4B | ||
| Q3 25 | — | $21.4B | ||
| Q2 25 | — | $21.0B | ||
| Q1 25 | — | $20.1B | ||
| Q4 24 | $36.3B | $20.1B | ||
| Q3 24 | — | $20.9B | ||
| Q2 24 | — | $20.2B | ||
| Q1 24 | — | $19.3B |
负债/权益比FMSTT
| Q4 25 | — | 0.54× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.64× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.9B | $1.2B |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 6.67× | 1.96× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FMSTT
| Q4 25 | $2.9B | $1.2B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | — | $692.1M | ||
| Q1 25 | — | $339.5M | ||
| Q4 24 | $2.6B | $899.9M | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $695.9M | ||
| Q1 24 | — | $247.2M |
自由现金流FMSTT
| Q4 25 | — | — | ||
| Q3 25 | — | $935.6M | ||
| Q2 25 | — | $602.2M | ||
| Q1 25 | — | $220.6M | ||
| Q4 24 | — | $774.3M | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $623.0M | ||
| Q1 24 | — | $163.4M |
自由现金流率FMSTT
| Q4 25 | — | — | ||
| Q3 25 | — | 16.3% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 15.9% | ||
| Q3 24 | — | 22.3% | ||
| Q2 24 | — | 11.7% | ||
| Q1 24 | — | 3.9% |
资本支出强度FMSTT
| Q4 25 | — | — | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 2.0% |
现金转化率FMSTT
| Q4 25 | 6.67× | 1.96× | ||
| Q3 25 | — | 1.18× | ||
| Q2 25 | — | 0.79× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | 20.20× | 1.49× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 0.92× | ||
| Q1 24 | — | 0.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FMS
暂无分部数据
TT
| Services | $2.8B | 55% |
| Other | $2.3B | 45% |
